Danielle_Path
Well-known member
ByeByeBackfat said:
If you don't have government insurance, use the Ozempic savings card too: https://www.ozempic.com/savings-and-resources/save-on-ozempic.html. GoodRx works as well: https://www.goodrx.com/ozempic
-
This forum is for informational purposes only and does not provide medical advice. Read our Medical Disclaimer. | Privacy | Terms | About | Cookie Policy | Editorial Policy | This site may contain sponsored content and affiliate links.
Pharma greed - US vs UK?
- Thread starter HeartSquad
- Start date
If you don't have government insurance, use the Ozempic savings card too: https://www.ozempic.com/savings-and-resources/save-on-ozempic.html. GoodRx works as well: https://www.goodrx.com/ozempic
Hawk_Story798
Member
Check out the hot pepper group if you're interested—details are linked there.
cocoa_roaster
Member
the drug pricing policy pressure on Canada is a real variable for anyone tracking cross-border pharmaceutical access - the political push to raise Canadian prices as a lever for lowering US prices has been a consistent feature of recent US trade negotiations and has implications for what the Canadian access pathway looks like in 12-24 months. the generic access window that exists now may tighten depending on how that negotiation resolves
tinyonhold54
Member
the US-specificity of the pricing article reflects the genuine pricing isolation the US pharmaceutical market operates under - the reference pricing systems in most European countries cap what manufacturers can charge in a way that the US system does not. the worst-in-Europe comment from the manufacturer is the inverse of the same situation; a country with strong reference pricing produces lower revenue for the manufacturer and lower cost for the patient
quirky-logger
Member
the taxpayer-funded research converted to private monopoly pricing is one of the more straightforward critiques of how pharmaceutical development is structured - the public funding of basic and early-stage research that makes drug development possible does not translate into any pricing constraint on the resulting products. the return on that public investment flows almost entirely to shareholders rather than to the population that funded it
tipsy-traveler8
Member
It's reality. The UK is not used to paying for anything health related, since drug companies made all their profit in America Europe could get everything really for free. really The system worked great for them, then a small price raise and suddenly the sky is falling.
tipsyramen
Well-known member
UK too. Prices nearly doubled since this time in 2025, and now the fifth dose has been removed. Effectively Eli Lilly has hit us with an 87.5% increase. Typical Big Pharma behavior. Greedy bastards.